Biomarkers
In Parkinsons 2026, this session focuses on the discovery and application of biomarkers for Parkinsons disease, emphasizing their role in early detection, accurate diagnosis, and monitoring disease progression. It explores advances in molecular, Genetics, imaging, and digital biomarkers, along with their potential to improve clinical decision-making and support the development of targeted therapies, including Surgery-based approaches. The session also examines biomarker applications in related disorders such as Alzheimers disease and highlights findings from Epidemiology studies that are shaping personalized medicine and enabling more effective management of Parkinsons disease.
Tracks:
Track 3.1: Diagnostic Markers
Track 3.2: Molecular Biomarkers
Track 3.3: Imaging Biomarkers
Track 3.4: Fluid Biomarkers
Track 3.5: Genetic Markers